Fundraising FoxAvana
Lexington, US · Founded 2021 · 1 known investors
Find your way into Avana
Sign up to see every warm intro you have to Avana
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Avana team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Avana Health is a women's health company developing uterine health treatments for abnormal uterine bleeding (AUB) and postpartum hemorrhage (PPH), and is preparing for its first clinical trials. Its treatments target unmet needs in maternal and gynecological care and are intended to be affordable and accessible to providers globally.
Founders & leadership
Avana was founded in 2021 by John Morehead and Peter Pacult, MBA.
JM
PP
Peter PacultChief Executive OfficerPeter Pacult co-founded Avana Health and serves as its CEO; he previously worked in finance for 11 years at a family business, rising to Vice President and Director of Research and Development, and held operational and strategic roles at a pharmaceutical startup focused on cardiovascular and metabolic disease treatment.
MR
Michael RoyalsChief Science OfficerMichael Royals is Chief Science Officer at Avana Health, where he leads the development of uterine health treatments for abnormal uterine bleeding and postpartum hemorrhage. He has held leadership roles in medical product development spanning business development, preclinical and clinical evaluation, regulatory affairs, and market development, with recent experience integrating immunization technology into international public health programs.
HS
Howard SettleChief Financial OfficerHoward Settle is an executive and entrepreneur who previously founded a company that reached $750M valuation and subsequently donated significant wealth to charitable causes. He is an angel investor in Avana Health, a women's health company developing treatments for abnormal uterine bleeding and postpartum hemorrhage.
AM
Angela MoreheadDirector of Research
Investors · 1
Reported raises · per SEC filings
Form D private placements$3M disclosed across 3 rounds · 2022–2025
▶$2.8MraisedDec 2025 · 29 investors · PharmaceuticalsRule 506(b)
▶$2.8MraisedDec 2025 · 29 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Peter PacultExecutive Officer, Director
- Howard SettleExecutive Officer, Director
- John MoreheadExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $2.8M
- Minimum investment
- $50K
- Proceeds to insiders
- $600K
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$120KraisedAug 2023 · 1 investors · Other Health CareRule 506(b)
▶$120KraisedAug 2023 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Howard SettleExecutive Officer, Director
- Peter PacultExecutive Officer, Director
- John MoreheadExecutive Officer, Director
- Offering amount
- $900K
- Amount sold
- $120K
- Minimum investment
- $30K
- Proceeds to insiders
- $12K
- First sale
- Jul 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$127.5KraisedNov 2022 · 2 investors · PharmaceuticalsRule 506(b)
▶$127.5KraisedNov 2022 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- John MoreheadExecutive Officer, Director
- Peter PacultExecutive Officer, Director
- Howard SettleExecutive Officer, Director
- Offering amount
- $510K
- Amount sold
- $127.5K
- Minimum investment
- $25.5K
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
MedscapeMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.
.webp)
AMBOSSAMBOSS is a digital medical knowledge platform serving doctors, medical students, and healthcare professionals worldwide with study materials, clinical reference content, and exam preparation tools. The platform serves over one million users across more than 180 countries and has been adopted by major medical schools and hospital networks.
Companies working in the same space as Avana.
Frequently asked questions
- What does Avana do?
- Avana Health is a women's health company developing uterine health treatments for abnormal uterine bleeding (AUB) and postpartum hemorrhage (PPH), and is preparing for its first clinical trials. Its treatments target unmet needs in maternal and gynecological care and are intended to be affordable and accessible to providers globally.
- Who founded Avana?
- Avana was founded by John Morehead, Peter Pacult, MBA in 2021.
- Who are Avana's investors?
- Avana's investors include Keyhorse Capital.
- How much funding has Avana raised?
- Avana has disclosed $3M raised across 3 rounds.
- Where is Avana headquartered?
- Avana is headquartered in Lexington, US.